Latest Stories (2024)

July 15th, 2024. Health. Loneliness Raise the Risk of Stroke? Study Finds Link Between the Two

July 10th, 2024. Being Patient. In Menopause, Estrogen Drops — Here’s How the Brain Reacts

July 9th, 2024. Being Patient. Considering Enrolling in a Dementia Clinical Trial? 6 Things You Should Know

July 8th, 2024. Being Patient. How Do Alzheimer’s Clinical Trials Work? And Other FAQs

July 3rd, 2024. Being Patient. FDA Approves New Alzheimer’s Drug Kisunla

July 3rd, 2024. Being Patient. Why the ADDF Is Betting $5M on This Experimental Alzheimer’s Drug

July 2nd, 2024. Being Patient. Former Cassava Advisor Indicted for Fraud, 2 Senior Employees Under Investigation

June 19th, 2024. Being Patient. How—and Why—To Make New Friends When You’re Older

June 18th, 2024. Ricochet Media. Canadians with disabilities remain locked in ‘legislated poverty,’ and many want to die

June 18th, 2024. Being Patient. Do Statins Cause Dementia? Here’s What the Science Says

June 17th, 2024. Being Patient. I Have Two Copies of Gene ApoE4. Do I Have Alzheimer’s Disease?

June 13th, 2024. Being Patient. The Mysterious Link Between Little Blobs of Brain Fat and the ‘Alzheimer’s Gene’

June 12th, 2024. Being Patient. ‘I’m Worried I Have Early Signs of Dementia. My Doctor Isn’t Taking Me Seriously’

June 11th, 2024. Being Patient. FDA Advisory Committee Recommends Approval of New Alzheimer’s Drug

June 10th, 2024. Being Patient. Wegovy and Ozempic Cost So Much, U.S. Lawmakers Are Intervening

June 4th, 2024. Being Patient. How to Read News Articles About Dementia — And Spot Hype and Exaggeration

May 28th, 2024. Being Patient. APOE4 Jacks Alzheimer’s Risk. This Gene Could Be an Antidote

May 27th, 2024. Being Patient. Annovis Bio’s Experimental Alzheimer’s Capsule Falls Short in Latest Trial

May 20th, 2024. Being Patient. Cleaner Air Could Spare 188,000 Americans From Dementia Each Year

May 13th, 2024. Atmos Earth. Shady Science: The Dangers of Secret Solar Geoengineering

May 10th, 2024. Being Patient. ‘I Discovered I Had Obstructive Sleep Apnea—Here’s How It Affected My Brain’

May 8th, 2024. Being Patient. Tau Protein: Coming to New Alzheimer’s Diagnostics and Treatments Near You

May 7th, 2024. Being Patient. Exploring Flashing Lights and Sounds to Slow Alzheimer’s Brain Shrinkage

April 30th, 2024. Being Patient. Alzheimer’s Rates Are Highest In These Counties—But No Leqembi Access

April 29th, 2024. Being Patient. Alzheimer’s Drug Types 101: What Are Biologics?

April 26th, 2024. Being Patient. Alzheimer’s Drug Types 101: What Are Small Molecule Drugs?

April 24th, 2024. Being Patient. How Policymakers Around the World Are Planning for a Dementia Surge

April 18th, 2024. Being Patient. ‘Blue Pee’ Saga Continues: Scientists Still Skeptical About TauRx Alzheimer’s Pill

April 17th, 2024. Being Patient. Unlocking the Secrets of ‘Superagers’: 3 Insights Into Alzheimer’s Resilience

April 9th, 2024. Being Patient. Can Multivitamins Slow Cognitive Decline By Two Years? Here’s What Experts Say

April 8th, 2024. Being Patient. Insurers Could Deny Coverage to People With Alzheimer’s Risk Genes

April 1st, 2024. Being Patient. What Is Alzheimer’s Disease and How Is It Diagnosed?

March 25th, 2024. Being Patient. Blurred Vision and Hallucinations: The First Signs of a Rare Form of Alzheimer’s

March 20th, 2024. Being Patient. Carrying Alzheimer’s Drugs Into the Brain on Waves of Sound

March 19th, 2024. Being Patient. How AI Is Turbocharging Alzheimer’s Brain Scans

March 13th, 2024. Being Patient. Could Your Smartphone Tell You’re Developing Cognitive Impairment?

March 13th, 2024. Being Patient. Alzheimer’s Clinical Trials and News: 2024 Q1 Round-up

February 27th, 2024. Being Patient. Dementia Biomarkers 101: What is Tau?

February 23rd, 2024. Being Patient. Neurologists Warn: Galantamine Brain Supplements Contaminated With Bacteria

February 21st, 2024. Being Patient. Viagra May Cut Dementia Risk—But Don’t Get Too Excited

February 21st, 2024. Being Patient. 5 Things You Need to Know About Blood Tests for Alzheimer’s

February 16th, 2024. Being Patient. 4 Frustrating Things I Learned Reporting On Alzheimer’s Blood Tests

February 14th, 2024. Being Patient. Alzheimer’s Biomarker Tests Could Screw Up Your Insurance

February 12th, 2024. Being Patient. Your Guide to Alzheimer’s Blood Tests: Pricing, Accuracy, and Where to Get One

February 5th, 2024. Being Patient. 5 Reasons Black Americans Have Higher Dementia Risk

February 2nd, 2024. Being Patient. No More Aduhelm: Biogen Halts Sales of Alzheimer’s Drug

February 2nd, 2024. Being Patient. Testing for Racism: Here’s Why Alzheimer’s Tests Won’t Necessarily Work In Black Patients

January 31st, 2024. TVO. Breathing room: Why parents and experts are calling for a clean-air revolution in schools

January 31st, 2024. Being Patient. How Reminiscence Therapy Can Help People With Dementia Remember The Past

January 23rd, 2024. Being Patient. Scientists Ask A Gutsy Question: Do Alzheimer’s and Parkinson’s Start in the Intestines?

January 18th, 2024. Being Patient. What Is the Difference Between Dementia and Alzheimer’s?

January 17th, 2024. Being Patient. Aromatherapy Vs. Scent-Based Therapy for Dementia

January 16th, 2024. Being Patient. 3 High-Tech New Approaches to Alzheimer’s Diagnosis

January 15th, 2024. Being Patient. The Relationship Between Epilepsy, Cognitive Decline, and Dementia

January 11th, 2024. Being Patient. Designing Alzheimer’s Drugs to Conduct the Immune System’s Orchestra

January 9th, 2024. The Sick Times. Long Covid advocates face challenges, potential discrimination with billboard campaigns

Highlights

Artificial Intelligence (AI)

The urgent problem of regulating AI in medicine

Proto Life

How should medical AI be regulated, and who is responsible when deadly mistakes occur?

Help! My teacher thinks I cheated.

New York Times

Chatbots can do your homework, some schools are freaking out about it.

How new AI tools for doctors could worsen racial bias in healthcare

The Daily Dot

Experts are worried these ChatGPT-like apps may be misused.

Microsoft released an AI that answers medical questions, but it’s wildly inaccurate

Futurism

Microsoft’s medical AI is pretty impressive — except when it claims vaccines might cause autism, and that hospitals are haunted by ghosts.

Radiologists prone to mistakes because of AI

Oncology Compass

AI was supposed to help radiologists screen for cancer more accurately. Instead AI is making them doubt their own expertise and inadvertently harming their patients.

Chronic Illness and COVID

Breathing room: Why parents and experts are calling for a clean-air revolution in schools

TVO

Since August 2020, Ontario’s Ministry of Education has invested more than $665 million in improving ventilation and filtration in schools. But experts say the government isn’t doing enough — and that there’s insufficient transparency and monitoring.

Long Covid advocates face challenges, potential discrimination with billboard campaigns

The Sick Times

In response to the lack of support, people with Long Covid in the U.S., Canada, U.K., and Europe are buying billboard ads to raise awareness about the disease and promote the urgent need for clinical trials. However, as some billboard efforts in the U.S. have run into roadblocks, legal experts say there’s a potential case that advocates may be experiencing discrimination under the Americans with Disabilities Act (ADA).

Canada’s MAID policy is facilitating death by poverty

Ricochet Media

A 56-year-old Vancouver woman says she will die this month because British Columbia’s provincial government is refusing to cover essential health costs for her disabling illness.

Does the microbiome hold the key to ME/CFS?

The Guardian’s Scientific Observer

Often dismissed by the medical establishment, people with complex illnesses such as ME and Long COVID are taking the hunt for treatments into their own hands.

What Long-COVID clinics can — and can’t — do for you

TVO

Thousands of Ontarians are dealing with significant post-COVID symptoms and are desperate for answers. Where can they turn?

Stanford Long COVID study blows up because of unmasked staff

The Daily Beast

A long COVID clinical trial at Stanford Medicine is in chaos after participants felt unsafe because staff did not wear masks.

Why Canada’s seeing a grim rise in medically assisted death

The Daily Beast

“I won’t be able to maintain housing and I’m not well enough to live on the street.”

‘I’m the only one still masking’: What it’s like to still be COVID-cautious at work

Fast Company

Two public-facing employees share the pressure they felt to remove their masks in the workplace.

Climate and Energy

How energy intensive are AI apps like ChatGPT

The Weather Network

So far there's little information about how much energy their AI chatbots are using, especially how much is from renewable sources.

Wildfire smoke may pose risks for brain health

The Weather Network

Human-caused climate change ‘loads the dice’ for wildfire seasons, increasing exposure to the known health risks from wildfire smoke. Researchers are now focusing on the risks to our brains.

Crypto mines are making life a ‘daily hell’ in this town

The Daily Beast

“The natural beauty and tranquility of our area is in jeopardy,” C. Roberson’s petition on Change.org reads. “Your community could be next.”

Local Texans lay into Bitcoin miners exploiting energy woes

The Daily Beast

Jackie Sawicky has a message for Bitcoin miners moving into Navarro County, Texas: “Don’t piss on our boots and tell us it’s raining.”

Health

The Truth About Brain Boosting Supplements

Being Patient

Do brain supplements work? Even though they’re sold in grocery stores and endorsed by celebrities, science does not support most claims made by nootropic brands.

You probably don’t need that probiotic. Here’s why.

Time Health

Probiotic supplements are touted as a way to make the trillions of microbes in our gut healthier.

Neuroscience

Why neurologists are calling Quest’s rapid Alzheimer’s test an absolute catastrophe?

Being Patient

Almost anyone can take this quick test for Alzheimer’s without even going to the doctor. Some neurologists are saying it’s a terrible idea.

Are doctors missing millions of cases of mild cognitive impairment?

Being Patient

We found the recent news that 92 percent of MCI cases go undiagnosed hair-raising. We asked our bank of experts for their feedback. What we heard: Too much hype, unnecessary panic, and a strange and misplaced plug for a new class of drugs.

Why is a dementia diagnosis so hard to get right?

Being Patient

Neurologists explain why different kinds of dementia are so hard to accurately diagnose, why it’s so critical to get your diagnosis right, and how to advocate for yourself until you get the answer.

The history of Alzheimer’s disease: from ancient times to today

Being Patient

Although humans have known for thousands of years that some older people develop memory and cognitive problems, the idea that this was actually a disease — and not a normal part of aging — is less than 100 years old.

Psychedelics are surging - at the expense of indigenous communities

The Daily Beast

A growing new industry around psychedelic therapy is utilizing biopiracy tactics to steal indigenous knowledge of new drugs.

Will this drug helps us beat Alzheimer’s or will it doom its makers instead?

The Daily Beast

Cassava Sciences’ new drug has no shortage of supporters and critics volleying accusations of misconduct, conflicts of interest, and online harassment.

Technology

Meet the Neuralink cofounder who left and started a competitor that's now rapidly catching up

Futurism

In the world of brain-computer interfaces, there are few names gaining notability faster than Max Hodak, the founder of Science Corp — a newcomer in the industry that kicked off just last year, but which has already raised $160 million in total funding.

Departed Neuralink cofounder locks down $47 million for secretive neuroscience startup

Futurism

When Neuralink co-founder Max Hodak announced his enigmatic departure from the company earlier this year, it was unclear whether he quit due to disagreements with fellow co-founder Elon Musk or if he was fired for moving too slow on clinical trials.